Inflammation refers to the defensive response of living tissue with vascular system to pro-inflammation cytokines and local injury, which is centered in vascular response. Inflammation is manifested as physiological responses initiated by stimuli such as trauma, bleeding, and pathogenic infection. These responses include redness, swelling, fever, and pain. Inflammation is a protective measure of the innate immune system to remove harmful irritants or pathogens or to promote repair, which is different from the acquired immune system that targets specific pathogens. Inflammation can be induced by burn, chemical stimulus, frostbite, toxin, pathogen infection, and necrocytosis. Studies have confirmed that persistent inflammation caused by infection or autoimmunity can progress to tumors. The available therapies for treating inflammation in western medicine mainly include non-steroidal anti-inflammatory drugs, steroids, and physiotherapy. With the gradual recognition and acceptance worldwide, traditional Chinese medicine (TCM) has attracted extensive attention in anti-inflammation attributed to the excellent performance and a growing number of clinicians and researchers have devoted to the study of anti-inflammation with TCM. The discovery of a variety of anti-inflammatory Chinese medicinal materials and the study of effective therapies such as acupuncture and moxibustion provide powerful tools to fight inflammation. Despite the rapid advancement of modern technology and medical care, the mechanisms of many anti-inflammatory drugs remain unclear, and new drugs are yet to be developed. Researchers in China have actively developed new Chinese and western anti-inflammatory drugs, optimized chemical drug structures, elucidated drug action mechanisms, explored the potential of acupuncture and moxibustion in treating inflammation, and improved the nursing of patients with inflammation, making great contribution to the treatment of inflammation.
Since 2014, Chinese Acupuncture & Moxibustion, Acupuncture Research, China Journal of Chinese Materia Medica, Acta Pharmaceutica Sinica, Chinese Pharmacological Bulletin, Chinese Journal of Integrated Traditional and Western Medicine, Chinese Pharmaceutical Journal, The Chinese Journal of Clinical Pharmacology, Journal of Chinese Medicinal Materials, Chinese Archives of Traditional Chinese Medicine, Liaoning Journal of Traditional Chinese Medicine, Chinese Traditional and Herbal Drugs, Disease Surveillance, and Chinese Journal of Nursing have joined the Journal Translation Project (JTP, http://jtp.cnki.net/bilingual). As of 2020, 5 049 articles from these journals have been included in JTP and published in both Chinese and English, which has enhanced the international influence of these journals. To further promote the international dissemination of medical and pharmaceutical journals published in China and to inform more readers about the latest progress of inflammation treatment in the medical and academic sectors in China, China National Knowledge Infrastructure collaborated with the editorial offices of these journals to constitute a panel of experts to select 76 excellent articles on inflammation research, which have been compiled into the book Inflammation (English edition) as part of China’s Medicine Progress Series (English edition). These articles included were recommended by the editorial boards of the journals in which they were originally published, covering theoretical, drug, mechanism, clinical, and nursing research and fully demonstrating the cutting-edge advances in inflammation treatment in China, with methodological support and objective conclusions. The original articles are published in Chinese, and this book is a compilation of English versions of selected articles.
As the editor-in-chief, I believe this book will provide useful experience and methods from the Chinese medical community for inflammation treatment worldwide. This book provides scientific, practical, and up-to-date literature for global medical professionals and further enhances the international influence of medical and pharmaceutical journals published in China.
Editor-in-Chief: LIU Changxiao收起